Nicotine and Chronic Kidney Disease
Nicotine and Chronic Kidney Disease
批准号:
7933933
负责人:
EDGAR A JAIMES
金额:
$57.3万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-20 至 2012-06-30
关键词:
AffectAngiotensin IIAnimal ModelAnimalsArtsAtherosclerosisBiological AssayBlood VesselsCell ProliferationChronic Kidney FailureClinicalClinical ResearchCollagen Type IVCyclinsDahl Hypertensive RatsDataDepositionDiabetes MellitusDialysis procedureEnd stage renal failureExtracellular MatrixExtracellular Matrix ProteinsFibronectinsGoalsGrowthHumanHypertensionImmunohistochemistryIn VitroIncidenceIndividualInjuryKidneyLung diseasesMediatingMediator of activation proteinModelingMolecular BiologyMolecular Biology TechniquesMorbidity - disease rateNational Health and Nutrition Examination SurveyNeuraxisNicotineOutcomePathogenesisPathway interactionsPatientsPlayPopulationPrevalencePreventiveProcessProductionPropertyProstaglandin-Endoperoxide SynthaseProstaglandinsProteinuriaPublic HealthPulmonary HypertensionReactive Oxygen SpeciesRenal glomerular diseaseResearchRiskRisk FactorsRoleSignal TransductionSmokeSmokerSourceTechniquesTestingTherapeuticTissuesTobaccoUnited StatesVascular EndotheliumVascular Smooth MuscleWorkbasecancer typecardiovascular risk factorcell growthcigarette smokingcigarette smokingcostcyclooxygenase 2diabeticexperiencehemodynamicsin vivolung vascular injurymesangial cellmortalitynon-diabeticnovel strategiespreventpublic health relevancereceptorresponsesalt sensitivevasculogenesis
中文摘要
描述(由申请人提供):在美国,吸烟已被确定为可预防的发病率和死亡率的最重要原因。最近的临床研究表明,吸烟除了是一种重要的心血管风险外,还是糖尿病、高血压患者和肾小球疾病患者慢性肾脏疾病(CKD)进展的重要风险。吸烟促进慢性肾脏疾病进展的机制尚未阐明。尼古丁被认为是香烟烟雾中的一种化合物,可能在吸烟者的血管和肺损伤的发病机制中发挥作用。我们在此假设,尼古丁是一种稳定的产物,存在于香烟烟雾中,通过特定的尼古丁受体促进系膜细胞增殖和细胞外基质(ECM)沉积,从而激活参与细胞生长和损伤的通路,从而加速CKD的进展。我们将通过追求以下具体目标1来验证这一假设:确定尼古丁暴露在慢性肾脏疾病进展中作为危险因素的作用。这一目标的假设是,尼古丁通过增加纤维连接蛋白和IV型胶原等ECM蛋白的沉积,加速盐敏感型高血压动物模型中CKD的进展,与肾脏损伤有关。我们还将确定尼古丁引起的血流动力学变化对这些影响的作用,以及尼古丁受体在这些动物肾脏中的分布和表达。我们将使用一种综合的方法,利用几种药物阻滞剂来评估尼古丁在盐敏感性高血压模型中对肾脏损伤的影响;目标2:确定ROS和COX-2衍生的前列腺素在尼古丁在肾脏损伤中的作用。这一假说认为,活性氧(ROS)和COX-2衍生的前列腺素是盐敏感型高血压尼古丁诱导的肾损伤效应的重要介质。这些研究将在Dahl盐敏感大鼠身上进行,并利用生物测定、分子生物学和免疫组织化学技术相结合的方法来评估COX-2衍生的前列腺素和ROS在尼古丁诱导的肾损伤中的作用;目的3:建立尼古丁诱导的细胞增殖和细胞外基质沉积的信号转导机制。这一目标的假设是尼古丁激活了几个参与细胞增殖和基质产生的途径,包括PKC激活、Cres和Src/Raf-1/MAPK/Cyclins。这些研究将利用最先进的分子生物学技术在人类肾小球系膜细胞中进行。公共卫生相关性这些研究将确定尼古丁在慢性肾脏疾病进展中作为风险因素的作用,并将确定涉及的机制。这些研究将揭示可能解释吸烟对肾脏损伤有害影响的机制。这些研究将确定尼古丁在高血压合并肾脏损伤的动物模型中的作用。尼古丁是香烟烟雾的重要成分。我们将使用各种最先进的技术来评估尼古丁导致肾脏损伤的机制。
英文摘要
DESCRIPTION (provided by applicant): Cigarette smoking has been identified as the most important cause of preventable morbidity and mortality in the U.S. Recent clinical studies suggest that in addition to being an important cardiovascular risk, cigarette smoking is also an important risk for the progression of chronic kidney disease (CKD) in diabetics, hypertensives and patients with glomerular diseases. The mechanisms by which cigarette smoking promotes the progression of chronic kidney disease have not been elucidated. Nicotine has been proposed as a compound in cigarette smoke that may play a role in the pathogenesis of vascular and lung injury in smokers. We herein hypothesize that nicotine, a stable product present in large amounts in cigarette smoke, accelerates the progression of CKD by promoting mesangial cell proliferation and extracellular matrix (ECM) deposition via specific nicotine receptors and resulting in the activation of pathways involved in cell growth and injury. We will test this hypothesis by pursuing the following specific Aim 1: To identify the role of nicotine exposure as a risk factor in the progression of chronic kidney disease. The hypothesis for this aim is that nicotine accelerates the progression of CKD in animal model of salt sensitive hypertension that is associated with renal injury by increasing the deposition of ECM proteins such as fibronectin and type IV collagen. We will also determine the role of nicotine induced hemodynamic changes on these effects and the distribution and expression of nicotine receptors in the kidneys of these animals. We will use a comprehensive approach utilizing several pharmacologic blockers to assess the effects of nicotine on renal injury in a well validated model of salt sensitive hypertension; Aim 2: To identify the role of ROS and COX-2 derived prostaglandins on the effects of nicotine in renal injury. The hypothesis for this aim that reactive oxygen species (ROS) and COX-2 derived prostaglandins are important mediators of the effects of nicotine induced renal injury in salt sensitive hypertension. These studies will be performed in Dahl salt sensitive rats and utilizing a combination of bioassays, molecular biology and immunohistochemistry techniques to assess the role of COX-2 derived prostaglandins and ROS on nicotine induced renal injury; Aim 3: To establish the signal transduction mechanisms mediating cell proliferation and ECM deposition in response to nicotine. The hypothesis for this aim is that nicotine activates several pathways involved in cell proliferation and matrix production including PKC activation, CREs, and Src/Raf-1/MAPK/cyclins. These studies will be performed in human mesangial cells utilizing a combination of state of the art molecular biology techniques. PUBLIC HEALTH RELEVANCE These studies will determine the role of nicotine as a risk factor in the progression of chronic kidney disease and will identify the mechanisms involved. These studies will unveil mechanisms that may explain the deleterious effects of cigarette smoking on renal injury. These studies will determine the role of nicotine, an important component of cigarette smoke, on kidney damage in an animal model of high blood pressure that is accompanied by kidney injury. We will use a variety of state of the art techniques to assess the mechanisms by which nicotine induces renal injury.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/ijms14036306
发表时间:
2013-03-19
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Bolisetty S, Jaimes EA]
通讯作者:
Jaimes EA
DOI:
10.2147/ibpc.s32649
发表时间:
2013
期刊:
Integrated blood pressure control
影响因子:
2.2
作者:
[Hovater MB, Jaimes EA]
通讯作者:
Jaimes EA
DOI:
10.1016/j.bcp.2013.07.014
发表时间:
2013-10-15
期刊:
BIOCHEMICAL PHARMACOLOGY
影响因子:
5.8
作者:
[Jain, Gaurav, Jaimes, Edgar A.]
通讯作者:
Jaimes, Edgar A.
DOI:
10.1161/hypertensionaha.110.150995
发表时间:
2010-06
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
[Feng W, Xing D, Hua P, Zhang Y, Chen YF, Oparil S, Jaimes EA]
通讯作者:
Jaimes EA
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
-
批准号:10275814
-
项目类别:
-
资助金额:$44.76万
-
财政年份:2021
-
负责人:EDGAR A JAIMES
-
依托单位:
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
-
批准号:10666430
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2021
-
负责人:EDGAR A JAIMES
-
依托单位:
Nanotechnology as a therapeutic approach in arteriovenous fistula maturation
-
批准号:10418812
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2021
-
负责人:EDGAR A JAIMES
-
依托单位:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
-
批准号:8391638
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:EDGAR A JAIMES
-
依托单位:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
-
批准号:8045940
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:EDGAR A JAIMES
-
依托单位:
ETS-1 and Vascular and Renal Injury in Salt Sensitive Hypertension
-
批准号:8198371
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:EDGAR A JAIMES
-
依托单位:
Nicotine and Chronic Kidney Disease
-
批准号:7524184
-
项目类别:
-
资助金额:$56.74万
-
财政年份:2009
-
负责人:EDGAR A JAIMES
-
依托单位:
Glomerular COX-2 in Hypertensive Renal Disease
-
批准号:7124216
-
项目类别:
-
资助金额:$14.79万
-
财政年份:2005
-
负责人:EDGAR A JAIMES
-
依托单位:
Glomerular COX-2 in Hypertensive Renal Disease
-
批准号:6984366
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2005
-
负责人:EDGAR A JAIMES
-
依托单位:
Glomerular COX-2 in Hypertensive Renal Disease
-
批准号:7285217
-
项目类别:
-
资助金额:$14.36万
-
财政年份:2005
-
负责人:EDGAR A JAIMES
-
依托单位:
海外基金